Soligenix, Inc. is a biopharmaceutical company specializing in rare disease treatments. It is developing products like SGX301 for cutaneous T-cell lymphoma and vaccines for ricin toxin and infectious diseases. Founded in 1987, the company is based in Princeton, NJ.